Direct-to-pcr viral diagnostic testing, a model to reduce cost and increase access for underserved communities

The global COVID-19 pandemic has driven rapid innovation in everything from therapeutics to diagnostics surrounding SARS-CoV-2 infections, while highlighting the need for cost efficient and accessible developments in these fields. Novel innovation that increases access to diagnostic testing in resource limited areas is still critical in supporting the response to COVID-19. In this manuscript we discuss the applications of a direct-to-PCR approach for SARS-CoV-2 detection which may serve as a viable option for addressing the need of rapid and accurate diagnostics in resource limited communities.